ARCHIVES

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 8 Issue 1, Spring 1994

April 13, 1994

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

Carbone to Give Up ECOG Chairmanship; DCE’s Adamson Receives Presidential Executive Award

October 6, 1989

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012